Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
9.37
+0.01 (0.11%)
At close: Nov 9, 2026, 4:00 PM EST
9.37
0.00 (0.00%)
After-hours: Nov 9, 2026, 8:00 PM EST
Pelthos Therapeutics Employees
Pelthos Therapeutics had 92 employees as of December 31, 2025. The number of employees increased by 81 or 736.36% compared to the previous year. That makes Pelthos Therapeutics the 31,975th largest employer in the world and 4,112th in the United States.
Employees
92
Change (1Y)
81
Growth (1Y)
736.36%
Revenue / Employee
$470,696
Profits / Employee
-$939,043
Market Cap
35.87M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 92 | 81 | 736.36% | 92 | 0 |
| Dec 31, 2024 | 11 | 3 | 37.50% | 4 | 7 |
| Dec 31, 2023 | 8 | 6 | 300.00% | 4 | 4 |
| Sep 30, 2023 | 3 | 0 | - | 3 | 0 |
| Dec 31, 2022 | 2 | 0 | - | 2 | 0 |
| Sep 30, 2022 | 3 | 1 | 50.00% | 3 | 0 |
| Jun 30, 2022 | 3 | - | - | 3 | 0 |
| Dec 31, 2021 | 2 | - | - | 2 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| BriaCell Therapeutics | 31 |
| INmune Bio | 21 |
| Veru Inc. | 20 |
| Serina Therapeutics | 16 |
| ProMIS Neurosciences | 11 |
| Hyperion DeFi | 9 |
| Annovis Bio | 7 |
| NanoViricides | 7 |
PTHS News
- 5 days ago - Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026 - GlobeNewsWire
- 10 days ago - Pelthos Therapeutics Inc trading resumes - TheFly
- 10 days ago - Pelthos Therapeutics Inc trading halted, volatility trading pause - TheFly
- 10 days ago - Pelthos Therapeutics to Combine with Castle Creek Biosciences, Creating Transformative Biotechnology Company Focused on Serious Diseases that Affect the Skin - GlobeNewsWire
- 13 days ago - Altimmune Appoints Peter Greenleaf and Alex Howarth, Two Leading Biotech Executives, to Board of Directors to Support Its Strategic Evolution - GlobeNewsWire
- 14 days ago - Pelthos Therapeutics price target lowered to $30 from $45 at Alliance Global - TheFly
- 4 weeks ago - Pelthos Therapeutics price target lowered to $40 from $50 at Lake Street - TheFly
- 4 weeks ago - Pelthos Therapeutics Announces Expanded Formulary Coverage for ZELSUVMI® (berdazimer) Topical Gel, 10.3% - GlobeNewsWire